Latest / Health and life sciences
FDA’s Digital Health Advisory Committee meets on generative AI medical devices
See how this story connectsThe FDA’s Digital Health Advisory Committee was scheduled to meet on 20-21 November 2024 to advise on total product lifecycle considerations for generative AI-enabled medical devices. The agenda covered premarket performance evaluation, risk management and postmarket monitoring, and a public docket (FDA-2024-N-3924) stayed open for comments until 21 January 2025.
Why it matters
Developers of generative AI medical tools got FDA’s questions on testing and monitoring such devices in public, with a docket open to their comments.
- When
- 20 Nov 2024
- ID
WTA-N-2024-0016- Where
- United States
- Who
- FDA
- Topics
- Medical devices, Clinical AI, Safety testing
Summary by wheresthe.ai, from Federal Register notice 2024-21074. Checked against the source on 9 Oct 2026.
Source copy: download the page as saved on 18 Oct 2026 (PDF). Also held by the Internet Archive.
Cite this story
WTA-N-2024-0016: “FDA’s Digital Health Advisory Committee meets on generative AI medical devices.” wheresthe.ai, 20 Nov 2024. https://wheresthe.ai/d/us-fda-dhac-generative-ai-devices-meeting-2024-11/ (source: Federal Register notice 2024-21074).
Spotted an error? Email [email protected].